A comparison of the irritant and allergenic properties of antiseptics
Tóm tắt
Over recent years, interest in the use of antiseptics has been reinforced as these molecules are not concerned by the problem of bacterial resistance. Whereas the in vitro efficacy of antiseptics has been well-studied, much less is known regarding their irritant and allergenic properties. This review provides an update on the comparative irritant and allergenic properties of commonly-used antiseptics in medicine nowadays. All antiseptics have irritant properties, especially when they are misused. Povidone-iodine has an excellent profile in terms of allergenicity. Allergic contact dermatitis is uncommon but is often misdiagnosed by practitioners, who confuse allergy and irritation. Chlorhexidine has been incriminated in some cases of allergic contact dermatitis; it is considered a relatively weak allergen, although it may rarely cause immunological contact urticaria and even life-threatening anaphylaxis. Octenidine is considered a safe and efficient antiseptic when used for superficial skin infections, however, aseptic tissue necrosis and chronic inflammation have been reported following irrigation of penetrating hand wounds. Polihexanide is an uncommon contact allergen as regards irritant and/or allergic contact dermatitis but cases of anaphylaxis have been reported. Considering the data available comparing the irritant and allergenic properties of major antiseptics currently in use, it should be acknowledged that all antiseptics may induce cutaneous side-effects. The present article reviews the most recent safety data that can guide consumers’ choice.
Tài liệu tham khảo
Osterlund A, Kahlmeter G, Haeggeman S, Olsson-Lijequist B. Staphylococcus aureus resistant to fusidic acid among Swedish children: a follow-up study. Scand J Infect Dis 2006; 38: 332–334.
Upton A, Lang S, Heffeman H, Mupirocin H. Staphylococcus aureus: a recent paradigm of emerging antibiotic resistance. J Antimicrob Chemother 2003; 51: 613–617.
Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF. Allergic and irritant contact dermatitis. Pathophysiology and immunological diagnosis. Eur J Dermatol 2009; 19: 1–8.
Vocanson M, Hennino A, Rozières A, Poyet G, Nicolas JF. Effector and regulatory mechanisms in allergic contact dermatitis. Allergy 2009; 64: 1699–1714.
Nosbaum A, Nicolas JF, Lachapelle JM. Pathophysiology of Allergic and Irritant Contact Dermatitis. In: Patch Testing and Prick Testing. A Practical Guide. Lachapelle JM, Maibach HI (eds), 3nd edn. Berlin, Springer, 2009; 3–9.
Goossens A: Le test semi-ouvert. Dermatologie Actualité (Bruxelles) 2003; 79: 16–17.
Hannuksela M, Salo H. The repeated open application test (ROAT). Contact Dermatitis 1986; 14: 221–227.
Lepoittevin JP. Molecular Aspects in Allergic and Irritant Contact Dermatitis. In: Johansen JD, Frosch PJ, Lepoittevin J-P, eds. Contact Dermatitis, 5th edn, Berlin, Springer, 2011; 91–110.
Müller G, Kramer A. Comparative study of in vitro cytotoxicity of povidone-iodine in solution, in ointment or in a liposomal formulation (Repithel®) and selected antiseptics. Dermatology 2006; 212: 91–93.
Quatresooz P, Xaufflaire-Uhoda E, Piérard-Franchimont C, Piérard GE. Regional variability in stratum corneum reactivity to antiseptic formulations. Contact Dermatitis 2007; 56: 271–273.
Nagasawa M, Hayashi H, Nakayoshi T. In vitro Evaluation of Skin Sensitivity of Povidone-Iodine and Others Antiseptics Using a Three-Dimensional Human Skin Model. Dermatology 2002; 204(Suppl 1): 109–113.
Kempf M, Kimble RM, Cuttle L. Cytotoxicity testing of burn wound dressings, ointments and creams: method using polycarbonate cell culture inserts on a cell culture system. Burns 2011; 37: 994–1000.
Fumal I, Braham C, Paquet P, Piérard-Franchimont C, Piérard GE. The beneficial toxicity paradox of antimicrobials in leg ulcer healing impaired by a polymicrobial flora: a proof-of-concept study. Dermatology 2002; 204(Suppl 1): 70–74.
Harding KG, Jones V, Price P. Topical treatment: which dressing to choose. Diabetes Metal Res Rev 2000; 16(suppl 1): S47–S50.
Langer S, SedighSalakdeh M, Goertz O, Steinau HU, Steinstrasser L, Homann HH. The impact of topical antiseptics on skin microcirculation. Eur J Med Res 2004; 29: 449–454.
Kalteis T, Lüring C, Schaumburger J, Perlick L, Bäthis H, Grifka J. Tissue toxicity of antiseptics. Z Orthop Ihre Grenzgeb 2003; 141: 233–238.
Röhner E, Hoff P, Winkler T, von Roth P, Bengt Seeger J, Perka C. Polyhexanide and hydrogen peroxide inhibit proteoglycan synthesis. J Histotechn 2011; 34: 35–39.
Li YC, Kuang YH, Lee SS, Huang FM, Chang YC. Cytotoxicity and genotoxicity of chlorhexidine on macrophages in vitro. Environ Toxicol 2012 Apr 4. doi: 10.1002/tox.21771. [Epub ahead of print].
Franz T, Vogelin E. Aseptic tissue necrosis and chronic inflammation after irrigation of penetrating hand wounds using Octenisept®. J Hand Surg Eur 2012; 37: 61–64.
Vanscheidt W, Harding K, Téot L, Siebert J. Effectiveness and tissue compatibility of a 12-week treatment of chronic venous ulcers with an octenidine based antiseptic: a randomized double-blind controlled study. Int Wound J 2012; 9: 316–323.
Bauer B, Majic M, Rauthe S, Bröcker EB, Kerstan A. Persistent swelling after flushing of an abscess with Octenisept®. Unfallchirurg 2012; 115: 1116–1119.
Hübner NO, Siebert J, Kramer A. Octenidine dihydrochloride, a modern antiseptic for skin, mucous membranes and wounds. Skin Pharmacol Physiol 2010; 23: 244–258.
Burd A, Kwok CH, Hung SC, et al. A comparative study of the cytotoxicity of silver-based dressings in monolayer cell, tissue explant, and animal models. Wound Rep Reg 2007; 15: 94–104.
Lachapelle JM. Antiseptics and Disinfectants. In: Kanerva’s Occupational Dermatology. 2nd edn. Rustemeyer Th, Elsner P, John SM, Maibach HI eds. Berlin, Springer, 2012; pp 385–395.
Lachapelle JM, de Prost Y. Place de la povidone iodée en dermatologie. Editions Ektopic, Paris, 2007.
Lachapelle JM. Occupational allergic contact dermatitis to povidone-iodine. Contact Dermatitis 1984; 11: 189–190.
Tosti A, Vincenzi C, Bardazzi F, Mariani R. Allergic contact dermatitis due to povidone iodine. Contact Dermatitis 1990; 23: 197–198.
Erdmann S, Herti M, Merk HF. Allergic contact dermatitis from povidone-iodine. Contact Dermatitis 1999; 40: 331–332.
Pecquet C. Allergy to iodine. Ann Dermatol Venereol 2003; 130: 795–798.
Lachapelle JM. Allergic contact dermatitis from povidone-iodine: a reevaluation study. Contact Dermatitis 2005; 52: 9–10.
Lachapelle JM. Thésaurismose cutanée par polyvinylpyrrolidone. Dermatologica 1966; 132: 476–489.
Calnan CD. Contact Dermatitis from drugs. Proc R Soc Med 1962; 55: 39–42.
Liippo J, Kousa P, Lalmmintausta K. The relevance of chlorhexidine contact allergy. Contact Dermatitis 2011; 64: 229–234.
Chemotechnique Patch Test Products, 2012.
Muston HL, Boss JM, Summerly R. Dermatitis from Ammonyx 1.0, a constituent of Hibiscrub. Contact Dermatitis 1977; 3: 347–348.
Rudzki E, Rebandel P, Grzywa Z. Patch tests with occupational contactants in nurses, doctors and dentists. Contact Dermatitis 1989; 20: 247–250.
Rietschel RL, Fowler JF Jr. Fisher’s Contact Dermatitis 6. BC Decker inc. Hamilton, Ontario, Canada, 2008.
Heinemann C, Sinaiko R, Maibach HI. Contact Urticaria and Anaphylaxis to Chlorhexidine. In: Marzulli and Maibach’s Dermatoxicology. 7th edn. Zhai H, Wilhelm K-P, Maibach HI eds. CRC Press, Boca Raton FL, 2008; 485–495.
Leysen J, Bridts C, Sabato V, Vercauteren M, Ebo D. Anaphylaxis during general anaesthesia: ten-year survey from a Belgian allergy clinic. European Academy of Allergy and Clinical Immunology, 16–20 June 2012, Geneva (poster 291).
Krautheim AB, Jermann THH, Bircher AJ. Chlorhexidine anaphylaxis: case report and review of the literature. Contact Dermatitis 2004; 50: 113–116.
Nagendran V, Wickin J, Ekbote A, et al. IgE-mediated chlorhexidine allergy: a new occupational hazard? Occup Med (Lond) 2009; 59: 270–272.
Kramer AW, Daeschlein G, Kammerlander G, et al. An assessment of the evidence on antiseptics: a consensus paper on their use in wound care. J Wound Care 2004; 13: 1–7.
Calow T, Oberle K, Bruckner-Tuderman L, Jakob T, Schumann H. Contact dermatitis due to the use of Octenisept in wound care. J Dtsch Dermatol Ges 2009; 7: 759–765.
Minnich KE, Stolarick R, Wilkins RG, Chilson G, Pitt SL, Unverdorben M. The effect of wound care solution containing polyhexanide and betaine on bacterial counts: results of an in vitro study. Ostomy Wound Manage 2012; 58: 32–36.
Lenselink E, Andriessen A. A cohort study on the efficacy of a polyhexanide-containing biocellulose dressing in the treatment of biofilms in wounds. J Wound Care 2011; 534: 536–539.
Schnuch A, Geier J, Uter W, Basketter DA, Jowsey IR. The biocide polyhexamethylene biguanide remains an uncommon contact allergen. Contact Dermatitis 2007; 56: 235–239.
Olivieri J, Eigenmann PA, Hauser C. Severe anaphylaxis to a new disinfectant: polyhexanide, a chlorhexidine polymer. Schweiz Med Wochensch 1998; 128: 1508–1511.
Kautz O, Schumann F, Degerbeck L, Venemalm L, Jakob T. Severe anaphylaxis to the antiseptic polyhexanide. Allergy 2010; 65: 1068–1070.
Kaehn K. Polyhexanide: a safe and highly effective biocide. Skin Pharmacol Physiol 2010; 23(suppl): 7–16.
Lansdow AB. Silver in health care: antimicrobial effects and safety in use. Curr Probl Dermatol 2006; 33: 17–34.
Leaper DJ. Silver dressings: their role in wound management. Int Wound J 2006; 3: 282–294.
Lidén C, Bruze M, Thyssen JP, Menné T. Metals. In: Johansen JD, Frosch PJ, Lepoittevin J-P, eds. Contact Dermatitis, 5thedn, Springer, Berlin, 2011: 643–679.
Corazza M, Virgili A. Airborne allergic contact dermatitis from benzalkonium chloride. Contact Dermatitis 1993; 28: 195–196.
Stanford D, Georgouras K. Allergic contact dermatitis from benzalkonium chloride in plaster of Paris. Contact Dermatitis 1996; 35: 371–372.
Dooms-Goossens A, Van Daele M, Bedert R, Marien K. Hexamidine isethionate: a sensitizer in topical pharmaceutical products and cosmetics. Contact Dermatitis 1989; 21: 270.
Le Coz CJ, Scrivener Y, Santinelli F, Heid E. Sensibilisation de contact au cours des ulcères de jambe. Ann Dermatol Venereol 1998; 125: 694–699.
Revuz J, Poli F, Wechsler J, Dubertret L. Dermatites de contact à l’hexamidine. Ann Dermatol Venereol 1984; 111: 805–810.
Fransway AL. The problem of preservation in the 1990’s: 3. Agents with prevention function independent of formaldehyde release. Am J Contact Dermat 1991; 2: 145–148.
Lachapelle JM, Tennstedt D. Low allergenicity of triclosan. Predictive testing in guinea pigs and in humans. Dermatologica 1979; 158: 379–383.
Magnusson B, Kligman AM. The identification of contact allergens by animal assay. The guinea-pig maximization test. J Invest Dermatol 1969; 52: 268–276.
Bertelsen RJ, Longnecker MP, Lovik M, et al. Triclosan exposure and allergic sensitization in Norwegian children. Allergy 2012; 68: 84–91.
Özkaya E, Bozkurt PK. An unusual case of triclosan-induced immunological contact urticaria. Contact Dermatitis 2013; 68: 121–123.